ClinicalTrials.gg
CompletedNCT04759950MindfitUpdated Mar 2, 2022

Exercise the Mind and Brain. A Multimodal Intervention in Stroke

An interventional study of Multicomponent Physical Activity Program and Mindfulness-Based Stress Reduction Program in Stroke, sponsored by University of Barcelona. Completed at 1 site in Spain. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2022-03-02.

Sponsored by University of Barcelona · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
141
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 323 studies in Stroke with a site in Spain — 73 open to participants now, 91 under way, 6 of them phase 3. Stroke · Spain.

Enrollment
92nd of 246
141 · median 70
Started
2020
with 20 others
No phase
159 of 323
50 open now
Registered
186th of 323
by date

Among the 323 studies in Stroke with a site in Spain, this one is the 92nd largest by enrollment of the 246 interventional ones that give a count, is one of 21 that started in 2020, is one of 159 with no phase, and was the 186th registered.

Stroke

8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.

Browse Stroke studies →

Open to participants now

73 of the 323 studies in Stroke with a site in Spain are open now. Recruiting first, the newest first:

68 more — sign in →

All 73 open studies →

A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →

Who these studies take

Of the 1,418 Stroke studies recruiting now, 698 (49%) set no upper age limit and 281 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.

This study: 18 Years to 80 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 323 studies in Stroke with a site in Spain, or all of them as a file.
02

Study summary

The main objective of MindFit Project is to develop an evidence-based multimodal investigation of combined non-pharmacological strategies in chronic stroke patients and clarify the neuroplasticity mechanisms underlying the benefits of physical exercise and mindfulness strategies combined with cognitive training on post-stroke recovery. The investigators have adopted a multidisciplinary and multimodal approach to provide a more integrative perspective using cognitive, social-psychological, biochemical, and neuroimaging measurements.

Read the detailed description

The MindFit Project is a multicentric, prospective, parallel, single-blinded, randomized controlled trial with a sample of 141 participants at 3 to 60 months after stroke. Participants are randomly allocated to one of three arms (through a simple randomizing procedure with a 1:1:1 ratio created with a random sequence generator software).

The first group (n=47) receives computer-based cognitive training (CCT) combined with a multicomponent physical exercise program. The second group (n=47) receives CCT combined with mindfulness-based stress reduction therapy. Finally, the third group (n=47), as an active control group, receives only CCT. All interventions last 12 weeks.

Within two weeks before the start of the interventions, and again at 3 months after completing the interventions, medical, cognitive, and physical assessments, neuroimaging, and biological samples collection are performed.

The objectives of this project are:

  1. To examine the effects of multimodal interventions in a population of chronic stroke patients on various domains: cognition, emotion, physical health, and quality of life.
  2. To examine specific plasticity effects of each of the three interventions regarding structural and functional magnetic resonance imaging (MRI) and how these changes may contribute to cognitive and emotional benefits.
  3. To study the molecular mechanisms by which the different types of interventions influence cognitive, emotional and brain benefits.
  4. To study interventions-induced microbiome changes and to explain how these changes may induce inflammatory and immune responses that may contribute to cognitive, emotional and brain benefits.
  5. To determine the demographic, clinical and genetic factors that may modulate cognitive, emotional and brain changes: baseline cognitive status; baseline cerebral status (atrophy, total intracranial volume); sex; age, educational level, intelligence.
03

Conditions studied

  • Stroke

Keywords

  • Neuroplasticity
  • stroke
  • neuroprotection
  • physical exercise
  • cognitive training
  • mindfulness
  • neuroimaging
  • intervention
  • randomization
  • blind
04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria:

  • Individuals aged 18-80 years old
  • Ischemic or hemorrhagic stroke
  • Stroke diagnoses between 3-60 months ago
  • To have consent from a physician to engage in an exercise intervention
  • Fluency in Catalan or Spanish (I.e., able to understand and speak)
  • Accept to take part in the study and sign the according to the Declaration of Helsinki.

Exclusion Criteria:

  • Cognitive impairment ( > 23)
  • Severe aphasia (item 9 of the NIHSS scale ≥ 2)
  • Severe sensory problems
  • Other neurological conditions apart from stroke
  • Severe pre-stroke psychiatric disorders (e.g., bipolar disorder, schizophrenia)
  • History of alcohol or other toxic abuse

Exclusion criteria only for MRI examination:

  • Claustrophobia
  • Medical device (e.g., pacemaker implants, stents)
  • Other metal objects in the body
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
141 participants (actual)

Study arms

  • Experimental
    Physical exercise & cognitive training group

    The Physical exercise \& cognitive training group receives a multicomponent physical exercise program combined with computer-based cognitive training.

    Behavioral: Multicomponent Physical Activity Program · Behavioral: Computerized Cognitive Training

  • Experimental
    Mindfulness & cognitive training group

    The Mindfulness \& cognitive training group receives mindfulness-based stress reduction therapy combined with computer-based cognitive training.

    Behavioral: Mindfulness-Based Stress Reduction Program · Behavioral: Computerized Cognitive Training

  • Active comparator
    Cognitive training group

    The Cognitive training group, as an active control group, receives only computer-based cognitive training.

    Behavioral: Computerized Cognitive Training

Interventions

  • BehavioralMulticomponent Physical Activity Program

    The proposed physical exercise intervention follows the American College of Sports Medicine (ACSM, 2017) and the American Stroke Association (Billinger et al., 2014) recommendations for stroke patients. The five weekly 45-minute sessions are divided into (1) three sessions guided and supervised telematically by a physical exercise specialist and a physiotherapist; (2) and two autonomous exercise sessions. The supervised sessions include exercises to work aerobic capacity, muscle strength and endurance, flexibility, agility, and balance. The intensity of these exercises is prescribed individually according to each participant's initial level and are gradually increased as the program progresses. Participants are encouraged to walk at a similar intensity on autonomous physical exercise days as performed in the guided sessions (moderate intensity), based on the Borg scale of perceived exertion (Borg, 1982).

  • BehavioralMindfulness-Based Stress Reduction Program

    This intervention follows an adaptation of the scheme and instructions of the official Mindfulness-Based Stress Reduction (MBSR) program designed by Jon Kabat-Zinn. It includes body scanning, sitting meditation, and gentle hatha yoga techniques. An accredited mindfulness instructor leads the 12-week online program, which comprises a presentation session, followed by eight intervention sessions (once a week, lasting 2.5 hours) and an intensive practice session interspersed between sessions six and seven. Apart from the supervised session, the therapist asks participants to carry out some independent practice daily.

  • BehavioralComputerized Cognitive Training

    An accredited neuropsychologist programs and supervises the computerized cognitive training through the Guttmann Neuropersonal Trainer (GNPT®) platform. The 12-week program consists of five sessions a week (45 minutes each) that include personalized activities planned to stimulate executive functioning, attention, processing speed, and memory.

06

What researchers measure

Primary outcomes

  1. Change in immediate verbal attention after receiving treatment

    Forward Digit Span (WAIS III)

    Time frame: 3 months (at baseline, 3 months from baseline)

  2. Change in verbal digit working memory after receiving treatment

    Backward Digit Span (WAIS III)

    Time frame: 3 months (at baseline, 3 months from baseline)

  3. Change in verbal memory after receiving treatment

    Rey Auditory Learning Test

    Time frame: 3 months (at baseline, 3 months from baseline)

  4. Change in visual memory after receiving treatment

    Rey's Complex Figure Test

    Time frame: 3 months (at baseline, 3 months from baseline)

  5. Change in executive function, verbal fluency after receiving treatment

    Phonetic Fluency is measured using the Controlled Oral Word Association Test, spanish adaptation, and semantic fluency test using the category Animal

    Time frame: 3 months (at baseline, 3 months from baseline)

  6. Change in executive function, inhibition after receiving treatment

    Stroop Test

    Time frame: 3 months (at baseline, 3 months from baseline)

  7. Change in executive function, set-switching task after receiving treatment

    Trail Making Test

    Time frame: 3 months (at baseline, 3 months from baseline)

  8. Change in language, naming after receiving treatment

    Boston naming Test

    Time frame: 3 months (at baseline, 3 months from baseline)

Secondary outcomes

  1. Changes in psychological distress

    Clinical Outcomes in Routine Evaluation (CORE-OM)

    Time frame: 3 months (at baseline, 3 months from baseline)

  2. Changes in depression and anxiety

    Depression Anxiety Stress Scale (DASS-21)

    Time frame: 3 months (at baseline, 3 months from baseline)

  3. Changes in wellbeing

    Ryff Scales of Psychological Wellbeing.

    Time frame: 3 months (at baseline, 3 months from baseline)

  4. Changes in Mindfulness

    Mindful Attention Awareness Scale (MAAS)

    Time frame: 3 months (at baseline, 3 months from baseline)

  5. Changes in White matter integrity

    White matter integrity: tractography

    Time frame: 3 months (at baseline, 3 months from baseline)

  6. Changes in Resting-state connectivity

    Resting state brain activity using fMRI

    Time frame: 3 months (at baseline, 3 months from baseline)

  7. Changes in brain volumetry

    Grey and white matter volume measured by MRI

    Time frame: 3 months (at baseline, 3 months from baseline)

  8. Molecular changes: growth factors (BDNF, SDF1-a, VEGF-A, IGF-1, and NGF), cortisol, protein C reactive, IL-6 and homocysteine levels

    Quantification of different biomarkers from blood samples.

    Time frame: 3 months (at baseline, 3 months from baseline)

  9. Changes in Microbiota data

    Bacterial composition of stool samples in terms of relative abundance

    Time frame: 3 months (at baseline, 3 months from baseline)

  10. Changes in Sleep

    Pittsburgh Sleep Quality Index (PSQI)

    Time frame: 3 months (at baseline, 3 months from baseline)

  11. Changes in Fitness

    Senior Fitness Test (SFT)

    Time frame: 3 months (at baseline, 3 months from baseline)

  12. Changes in stroke specific quality of life

    Stroke-specific Quality of Life Scale (ECVI-38)

    Time frame: 3 months (at baseline, 3 months from baseline)

  13. Changes in quality of life

    World Health Organization Quality of Life (WHOQOL-BREF)

    Time frame: 3 months (at baseline, 3 months from baseline)

  14. Changes in mental fatigue

    Fatigue Assessment Scale (FAS)

    Time frame: 3 months (at baseline, 3 months from baseline)

  15. Changes in physical activity:

    Spanish version of the reduced Minnesota leisure-time physical and activity questionnaire (VREM)

    Time frame: 3 months (at baseline, 3 months from baseline)

07

Study locations

1 site
  • Maria Mataro
    Barcelona, Spain
08

References and documents

Publications

  • Bermudo-Gallaguet A, Ariza M, Dacosta-Aguayo R, Agudelo D, Camins-Vila N, Boldo M, Carrera O, Vidal S, Ferrer-Uris B, Busquets A, Via M, Pera G, Caceres C, Gomis M, Garcia-Molina A, Tormos JM, Arrabe A, Diez G, Dura Mata MJ, Toran-Monserrat P, Soriano-Raya JJ, Domenech S, Perera-Lluna A, Erickson KI, Mataro M. Effects and mechanisms of mindfulness training and physical exercise on cognition, emotional wellbeing, and brain outcomes in chronic stroke patients: Study protocol of the MindFit project randomized controlled trial. Front Aging Neurosci. 2022 Sep 29;14:936077. doi: 10.3389/fnagi.2022.936077. eCollection 2022. PubMed 36248000 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Oct 2020 to primary completion in Jul 2021, 9 months.

Of 3,121 non-industry interventional studies with no phase under Stroke, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 46. This study's 9 months is below that.

Counting every sponsor, half of 3,265 studies reached it within 23 months; a quarter within 10 and three quarters within 46.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 31, 2020
First posted
Feb 18, 2021
StartActual
Oct 28, 2020
Primary completionActual
Jul 30, 2021
CompletionActual
Jan 30, 2022
Last update
Mar 2, 2022
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 2, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04759950
Collaborators
Fundació La Marató de TV3, Germans Trias i Pujol Hospital, Institut Guttmann, Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina, University of Pittsburgh
Responsible party
Maria Mataro Serrat (Professor, University of Barcelona) — Principal investigator
First posted
Feb 18, 2021
Start date
Oct 28, 2020
Primary completion
Jul 30, 2021
Completion
Jan 30, 2022
Last update
Mar 2, 2022

Study contacts

Maria Mataro, PhD
principal investigator · University of Barcelona

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion